{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T01:34:19Z","timestamp":1778204059520,"version":"3.51.4"},"reference-count":35,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>(1) Background: Hudson first described the procedure that includes en-block removal of an ovarian tumor fixed in the pelvis with the whole pelvic peritoneum and invaded surrounding structures. However, sometimes pelvic peritonectomy (PP) with or without shaving of the bowel serosa is not enough to achieve complete cytoreduction, and en-block rectosigmoid resection (RR) is necessary. This study aims to investigate the impact of bowel surgery on survival rates and morbidity of patients with advanced ovarian cancer. (2) Methods: We retrospectively analyzed patients with advanced ovarian cancer with cul-de-sac involvement that underwent debulking surgery at the 1st Department of Obstetrics\u2014Gynecology of \u201cPapageorgiou\u201d General Hospital, from 2017\u20132022. The primary outcomes were the survival rates and morbidity between PP and RR. (3) Results: A total of 93 patients met the inclusion criteria. Patients were categorized into two groups: Group A (34 patients) with RR and Group B (59 patients) with PP. There was no statistically significant difference in the majority of patients\u2019 characteristics and oncological outcomes. On the other hand, patients with RR had a significantly higher surgical complexity score (SCS), peritoneal cancer index (PCI), ICU admission, rate of postoperative complications, longer surgery duration and hospital stay. When comparing the duration of surgery, the RR group has significantly higher operation time during primary compared to interval debulking surgery. Concerning survival rates, there was no significant difference in progression-free (PFS) (p = 0.22) and overall survival (OS) (p = 0.85) between the two groups, while residual disease and postoperative complications were identified as independent prognostic factors for PFS and OS; (4) Conclusions: The modified Hudson procedure with RR is a safe and reproductible technique, but when complete gross resection can be achieved with PP, this technique is preferred in order to avoid increased patient\u2019s morbidity.<\/jats:p>","DOI":"10.3390\/cancers18030519","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T11:13:01Z","timestamp":1770289981000},"page":"519","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of Pelvic Peritonectomy vs. Rectosigmoid Resection During Hudson Procedure for Advanced Ovarian Cancer: 6-Year Experience of an ESGO-Certified Center"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2518-5657","authenticated-orcid":false,"given":"Dimitrios","family":"Zouzoulas","sequence":"first","affiliation":[{"name":"1st Department of Obstetrics & Gynecology, Aristotle University of Thessaloniki, \u201cPapageorgiou\u201d Hospital, 56429 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0362-5749","authenticated-orcid":false,"given":"Panagiotis","family":"Tzitzis","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics & Gynecology, Aristotle University of Thessaloniki, \u201cPapageorgiou\u201d Hospital, 56429 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iliana","family":"Sofianou","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics & Gynecology, Aristotle University of Thessaloniki, \u201cPapageorgiou\u201d Hospital, 56429 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katerina","family":"Tzika","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics & Gynecology, Aristotle University of Thessaloniki, \u201cPapageorgiou\u201d Hospital, 56429 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5357-4708","authenticated-orcid":false,"given":"Kimon","family":"Chatzistamatiou","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics & Gynecology, Aristotle University of Thessaloniki, \u201cPapageorgiou\u201d Hospital, 56429 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasilis","family":"Theodoulidis","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics & Gynecology, Aristotle University of Thessaloniki, \u201cPapageorgiou\u201d Hospital, 56429 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2545-8926","authenticated-orcid":false,"given":"Eleni","family":"Timotheadou","sequence":"additional","affiliation":[{"name":"Department of Oncology, Aristotle University of Thessaloniki, \u201cPapageorgiou\u201d Hospital, 56429 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grigoris","family":"Grimbizis","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics & Gynecology, Aristotle University of Thessaloniki, \u201cPapageorgiou\u201d Hospital, 56429 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6608-509X","authenticated-orcid":false,"given":"Dimitrios","family":"Tsolakidis","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics & Gynecology, Aristotle University of Thessaloniki, \u201cPapageorgiou\u201d Hospital, 56429 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"ref_1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"972","DOI":"10.6004\/jnccn.2022.0047","article-title":"NCCN Guidelines\u00ae Insights: Ovarian Cancer, Version 3.2022","volume":"20","author":"Armstrong","year":"2022","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.21037\/dmr-22-13","article-title":"Ovarian cancer peritoneal carcinomatosis: A narrative review","volume":"5","author":"Krishnan","year":"2022","journal-title":"Dig. Med. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ygyno.2023.10.018","article-title":"Impact of postoperative residual disease on survival in epithelial ovarian cancer with consideration of recent frontline treatment advances: A systematic review and meta-analysis","volume":"179","author":"Kim","year":"2023","journal-title":"Gynecol. Oncol."},{"key":"ref_6","first-page":"CD015048","article-title":"Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery","volume":"2022","author":"Bryant","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3802\/jgo.2010.21.2.75","article-title":"Maximal cytoreductive effort in epithelial ovarian cancer surgery","volume":"21","author":"Shih","year":"2010","journal-title":"J. Gynecol. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"LBA5500","DOI":"10.1200\/JCO.2025.43.17_suppl.LBA5500","article-title":"TRUST: Trial of radical upfront surgical therapy in advanced ovarian cancer (ENGOT ov33\/AGO-OVAR OP7)","volume":"43","author":"Mahner","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1136\/ijgc-2020-001640","article-title":"Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850)","volume":"30","author":"Fagotti","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(14)62223-6","article-title":"Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): An open-label, randomised, controlled, non-inferiority trial","volume":"386","author":"Kehoe","year":"2015","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Zouzoulas, D., Sofianou, I., Tzitzis, P., Theodoulidis, V., Chatzistamatiou, K., Timotheadou, E., Grimbizis, G., and Tsolakidis, D. (2025). The Role of Delayed Interval Debulking Surgery (DIDS) in the Surgical Treatment of Advanced Epithelial Ovarian Cancer: A Retrospective Cohort from an ESGO-Certified Center. Med. Sci., 13.","DOI":"10.3390\/medsci13040217"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"101650","DOI":"10.1016\/j.ijgc.2025.101650","article-title":"Survival after interval and delayed cytoreduction surgery in advanced ovarian cancer: A Global Gynaecological Oncology Surgical Outcomes Collaborative-Led Study (GO SOAR2)","volume":"35","author":"Gaba","year":"2025","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"102688","DOI":"10.1016\/j.ijgc.2025.102688","article-title":"SUROVA study: Global real-world treatment strategies and mortality risk prediction in advanced ovarian cancer","volume":"35","author":"Chiva","year":"2025","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Angeles, M.A., Viveros-Carre\u00f1o, D., Bonaldo, G., Bebia, V., Agust\u00ed, N., Luzarraga Aznar, A., Acosta, \u00da., Seminario, N., Pareja, R., and Gil-Moreno, A. (2025). Pelvic peritonectomy versus rectosigmoid resection in advanced epithelial ovarian cancer with Douglas pouch involvement: A systematic review and meta-analysis. Int. J. Gynecol. Cancer, 101983. online ahead of print.","DOI":"10.1016\/j.ijgc.2025.101983"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1471-0528.1968.tb02901.x","article-title":"A radical operation for fixed ovarian tumours","volume":"75","author":"Hudson","year":"1968","journal-title":"J. Obstet. Gynaecol. Br. Commonw."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/0090-8258(73)90029-2","article-title":"Surgical treatment of ovarian cancer","volume":"1","author":"Hudson","year":"1973","journal-title":"Gynecol. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1072-7515(03)00478-2","article-title":"Radical oophorectomy with primary stapled colorectal anastomosis for resection of locally advanced epithelial ovarian cancer","volume":"197","author":"Bristow","year":"2003","journal-title":"J. Am. Coll. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ygyno.2018.12.006","article-title":"En bloc pelvic resection for ovarian carcinomatosis: Hudson procedure in 10 steps","volume":"153","author":"Angeles","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.21614\/chirurgia.2827","article-title":"Surgical and Anatomical Basics of Pelvic Debulking Surgery for Advanced Ovarian Cancer\u2014The \u201cHudson Procedure\u201d as a Cornerstone of Complete Cytoreduction","volume":"118","author":"Kostov","year":"2023","journal-title":"Chirurgia"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"100359","DOI":"10.1016\/j.ijgc.2024.100359","article-title":"MINERVA Study: AnatoMo-Surgical ClassIficatioN of REctal Resection in Advanced OVArian Cancer","volume":"35","author":"Rosati","year":"2025","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ygyno.2017.06.007","article-title":"The impact of type and number of bowel resections on anastomotic leakage risk in advanced ovarian cancer surgery","volume":"146","author":"Grimm","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1006\/gyno.2001.6338","article-title":"Is the decision for colorectal resection justified by histopathologic findings: A prospective study of 100 patients with advanced ovarian cancer","volume":"83","author":"Hertel","year":"2001","journal-title":"Gynecol. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13244-024-01725-5","article-title":"Optimal debulking surgery in ovarian cancer patients: MRI may predict the necessity of rectosigmoid resection","volume":"15","author":"Zhao","year":"2024","journal-title":"Insights Imaging"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4103\/2156-7514.148265","article-title":"MRI of Uncommon Lesions of the Large Bowel: A Pictorial Essay","volume":"4","author":"Lee","year":"2014","journal-title":"J. Clin. Imaging Sci."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Tsolakidis, D., Chatzistamatiou, K., Markopoulou, E., Zouzoulas, D., Theodoulidis, V., Tzitzis, P., Sofianou, I., Kissoudi, K., Topalidou, M., and Timotheadou, E. (2025). Utilization of Ligasure\u00ae Maryland Jaw Open Sealer\/Divider with Nanocoating Improves Perioperative Parameters in Women with Advanced Ovarian Cancer Subjected to Cytoreductive Surgery. J. Clin. Med., 14.","DOI":"10.3390\/jcm14176293"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ygyno.2015.11.015","article-title":"Guidelines for pre- and intra-operative care in gynecologic\/oncology surgery: Enhanced Recovery After Surgery (ERAS\u00ae) Society recommendations\u2014Part I","volume":"140","author":"Nelson","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ygyno.2015.12.019","article-title":"Guidelines for postoperative care in gynecologic\/oncology surgery: Enhanced Recovery After Surgery (ERAS\u00ae) Society recommendations\u2014Part II","volume":"140","author":"Nelson","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1136\/ijgc-2021-002951","article-title":"European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery","volume":"31","author":"Fotopoulou","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1097\/DCR.0000000000003450","article-title":"Clinical Practice Guidelines Committee of the American Society of Colon and Rectal Surgeons. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for Preventing Surgical Site Infection","volume":"67","author":"Shogan","year":"2024","journal-title":"Dis. Colon Rectum"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.AOG.0000192407.04428.bb","article-title":"Aggressive surgical effort and improved survival in advanced-stage ovarian cancer","volume":"107","author":"Aletti","year":"2006","journal-title":"Obstet. Gynecol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.ejso.2011.09.003","article-title":"Douglas peritonectomy compared to recto-sigmoid resection in optimally cytoreduced advanced ovarian cancer patients: Analysis of morbidity and oncological outcome","volume":"37","author":"Gallotta","year":"2011","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1097\/IGC.0000000000001368","article-title":"Rectosigmoidectomy and Douglas Peritonectomy in the Management of Serosal Implants in Advanced-Stage Ovarian Cancer Surgery: Survival and Surgical Outcomes","volume":"28","author":"Demir","year":"2018","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"101946","DOI":"10.1016\/j.suronc.2023.101946","article-title":"Surgical efficacy and quality of wide resection of the pelvic peritoneum in patients with epithelial ovarian cancer","volume":"48","author":"Nishimura","year":"2023","journal-title":"Surg. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Tsolakidis, D., Zouzoulas, D., Tzitzis, P., Sofianou, I., Theodoulidis, V., Chatzistamatiou, K., Karalis, T., Topalidou, M., Timotheadou, E., and Grimbizis, G. (2025). The Role of Douglasectomy Instead of Random Biopsies in the Surgical Treatment of Presumed FIGO Stage I Ovarian Cancer. Cancers, 17.","DOI":"10.3390\/cancers17030419"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/3\/519\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T11:21:29Z","timestamp":1770290489000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/3\/519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["cancers18030519"],"URL":"https:\/\/doi.org\/10.3390\/cancers18030519","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]}}}